iomeprol has been researched along with Local Neoplasm Recurrence in 3 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Muenzfeld, H | 1 |
Mahjoub, S | 1 |
Roehle, R | 1 |
Pelzer, U | 1 |
Bahra, M | 1 |
Boening, G | 1 |
Hamm, B | 1 |
Geisel, D | 1 |
Auer, TA | 1 |
Kawamura, Y | 1 |
Ikeda, K | 1 |
Seko, Y | 1 |
Hosaka, T | 1 |
Kobayashi, M | 1 |
Saitoh, S | 1 |
Kumada, H | 1 |
Kitajima, K | 1 |
Murakami, K | 1 |
Yamasaki, E | 1 |
Domeki, Y | 1 |
Kaji, Y | 1 |
Fukasawa, I | 1 |
Inaba, N | 1 |
Suganuma, N | 1 |
Sugimura, K | 1 |
3 other studies available for iomeprol and Local Neoplasm Recurrence
Article | Year |
---|---|
Split-bolus vs. multiphasic contrast bolus protocol in patients with pancreatic cancer or cholangiocarcinoma.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Clinical Pr | 2019 |
Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Humans; Iopamidol; Liver Neopl | 2011 |
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.
Topics: Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iopamidol; Male; Middle Aged; N | 2008 |